[Psoriatic osteoarthropathy from the current viewpoint].
Application of scintigraphic techniques, especially bone scintigraphy, to a group of unselected psoriatic patients provided us with new knowledge about frequency, dimension, and valence of psoriatic osteoarthropathy. Thus scintigraphy was able to prove up to 90% of the incidences, whereas clinical and radiological investigation only revealed 7%. This result was achieved on account of better registration of the polytopical character as well as the evidence of potential early manifestations which could not be detected clinically or radiologically. In addition, we proved extraarticular manifestations of psoriatic osteopathy, especially in the skull, the long marrow bones, the ribs, and the distal phalanges.
D001842:Bone and Bones / Q000000981:diagnostic imaging; D003094:Collagen / Q000378:metabolism; D006801:Humans; D007596:Joints / Q000000981:diagnostic imaging; D010003:Osteoarthritis / Q000000981:diagnostic imaging*; D010710:Phosphates; D011565:Psoriasis / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D013670:Sodium Pertechnetate Tc 99m; D013667:Technetium; D017556:Technetium Compounds
D010710:Phosphates; D017556:Technetium Compounds; C046451:technetium Tc 99m phosphate; D013667:Technetium; D003094:Collagen; D013670:Sodium Pertechnetate Tc 99m
Die psoriatische Osteoarthropathie aus heutiger Sicht.